What clinical and laboratory findings should be evaluated in a patient with acute pancreatitis?

What to Evaluate in Acute Pancreatitis

In a patient with suspected acute pancreatitis, immediately obtain serum lipase (preferred over amylase), liver chemistries, triglycerides, calcium, and perform abdominal ultrasonography to establish diagnosis and determine etiology. 1, 2

Diagnostic Evaluation

Laboratory Tests for Diagnosis

• Serum lipase is the preferred diagnostic test over amylase, with levels ≥3 times the upper limit of normal confirming the diagnosis 3, 2, 4
• Lipase has superior sensitivity, especially in:
  • Alcohol-induced pancreatitis
  • Delayed presentations (remains elevated longer than amylase)
  • Patients presenting days after symptom onset 4, 5
• Do not order both amylase and lipase simultaneously - this increases cost without improving diagnostic accuracy 1, 5

Initial Laboratory Panel at Admission

Obtain the following tests immediately 1:

• Serum lipase (or amylase if lipase unavailable)
• Liver chemistries: AST, ALT, alkaline phosphatase, bilirubin
• Serum triglycerides (if not obtainable, measure fasting levels after recovery)
• Serum calcium
• Complete blood count
• Basic metabolic panel

Imaging for Diagnosis

• Abdominal ultrasonography at admission to identify gallstones or bile duct stones 1, 3
• Reserve CT/MRI for patients with unclear diagnosis or those failing to improve clinically - not needed for straightforward cases 2
• Contrast-enhanced CT is the gold standard when imaging is required 6, 4

Severity Assessment

Clinical Assessment Within 48 Hours

Evaluate for severity indicators 3, 7:

• Persistent organ failure (beyond 48 hours)
• APACHE II score in first 24 hours
• Obesity (independent risk factor)
• Clinical impression of severity

Laboratory Markers for Severity Stratification

• C-reactive protein >150 mg/L at 48 hours is the best available laboratory marker of severity 1, 3, 5
• Glasgow score ≥3 at 48 hours 3
• Do not repeat pancreatic enzymes daily - they have no value in assessing clinical progress or prognosis 5

Timing of CT for Severity Assessment

• Perform CT at 6-10 days in patients with:
  • Persistent organ failure
  • Signs of sepsis
  • Clinical deterioration 3
• Avoid routine early CT in the first 72 hours unless diagnosis is uncertain 1

Etiologic Evaluation

History Focus

Document 1:

• Previous gallstone symptoms or documentation
• Alcohol use pattern and quantity
• Medication history (prescription and over-the-counter)
• History of hypertriglyceridemia or hypercalcemia
• Family history of pancreatic disease
• Recent trauma
• Autoimmune disease history

Specific Etiologic Testing

• Elevated ALT >150 U/L suggests gallstone etiology (from liver chemistry panel)
• If triglycerides >1000 mg/dL, consider hypertriglyceridemic pancreatitis
• Repeat ultrasonography if initial study inadequate 1
• For patients >40 years with unexplained pancreatitis: perform CT or endoscopic ultrasound to exclude pancreatic malignancy 1

Common Pitfalls to Avoid

• Never rely on normal amylase alone to exclude pancreatitis - can be normal in hyperlipidemic pancreatitis, chronic pancreatitis exacerbations, or delayed presentations 5
• Do not order daily enzyme levels - wasteful and clinically unhelpful 5
• Do not skip ultrasonography - gallstones are the most common etiology and must be identified for definitive management 1, 3
• Do not perform extensive invasive workup for single episode in patients <40 years - reserve for recurrent episodes 1

Immediate Management Considerations

While evaluating, simultaneously initiate 2, 7:

• Aggressive IV fluid resuscitation (most beneficial in first 12-24 hours)
• Assess hemodynamic status immediately
• Admit patients with organ failure or SIRS to ICU/intermediate care
• Pain control
• Correct electrolyte abnormalities
• Supplemental oxygen as needed